Patrick C. Flannery
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Drug-Induced Hepatotoxicity and Protection 2
- Cannabis and Cannabinoid Research 2
- Genetics 7
- Glioma Diagnosis and Treatment 7
- Co-authors
- Satyanarayana R. Pondugula (12 shared papers)George Sakoulas (1 shared paper)Sridhar Mani (4 shared papers)Elaine S. Coleman (2 shared papers)Temesgen Samuel (1 shared paper)Wen Li Xie (1 shared paper)Muralikrishnan Dhanasekaran (5 shared papers)Sujatha Venkataraman (3 shared papers)
- Journals
- ACS Omega (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Communications (1 paper)Frontiers in Oncology (1 paper)Frontiers in Neurology (1 paper)
- Partner nations
- United StatesIndiaSaudi Arabia
In The Last Decade
Patrick C. Flannery
20 papers receiving 323 citations
Peers
Comparison fields: 5 of 57
- Genetics 78
- Pharmacology 39
- Oncology 51
- Neurology 27
- Toxicology 10
Countries citing papers authored by Patrick C. Flannery
This map shows the geographic impact of Patrick C. Flannery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Flannery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Flannery more than expected).
Fields of papers citing papers by Patrick C. Flannery
This network shows the impact of papers produced by Patrick C. Flannery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Flannery. The network helps show where Patrick C. Flannery may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick C. Flannery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 44 | |
| 2 | 2021 | 44 | |
| 3 | 2021 | 38 | |
| 4 | 2019 | 31 | |
| 5 | 2016 | 30 | |
| 6 | 2017 | 26 | |
| 7 | 2019 | 21 | |
| 8 | 2019 | 19 | |
| 9 | 2015 | 16 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2014 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2020 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About Patrick C. Flannery
Patrick C. Flannery is a scholar working on Pharmacology, Genetics, Oncology, Cancer Research and Pharmacology, having authored 22 papers that have together received 334 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Cannabis and Cannabinoid Research (2 papers), COVID-19 Clinical Research Studies (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper) and Ichthyology and Marine Biology (1 paper). The work is most often cited by research in Genetics (78 citations), Pharmacology (39 citations), Oncology (51 citations), Neurology (27 citations) and Toxicology (10 citations). Patrick C. Flannery has collaborated with scholars based in United States, India and Saudi Arabia. Frequent co-authors include Satyanarayana R. Pondugula, George Sakoulas, Sridhar Mani, Elaine S. Coleman, Temesgen Samuel, Wen Li Xie, Muralikrishnan Dhanasekaran, Sujatha Venkataraman, Adam L. Green and John A. DeSisto. Their work appears in journals such as ACS Omega, Molecular Cancer Therapeutics, Nature Communications, Frontiers in Oncology and Frontiers in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.